Crossmark

Helix pomatia agglutinin bound to surface glycans of small extracellular vesicles in-vitro and in-vivo increases in early and late stage breast cancer

Crossref DOI link: https://doi.org/10.1007/s12282-025-01724-4

Published Online: 2025-05-24

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cooper, Jamie

Airstone, Bethy

Beaman, Ellie

Carollo, Emanuela

Brooks, Susan Ann

Pink, Ryan Charles https://orcid.org/0000-0001-7501-558X
Funding

Funding for this research was provided by:

Oxford Brookes University (Nigel Groome Studentship)
License Information

Text and Data Mining valid from 2025-05-24

Version of Record valid from 2025-05-24
More Information

Article History

Received: 15 October 2024

Accepted: 11 May 2025

First Online: 24 May 2025

Declarations

:

: R. Pink is CEO of MetaGuideX Ltd, an exosome based diagnostic company, but not currently using this work.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Samples were purchased from Precision for Medicine Inc with ethical approval and consent under DHHS 45 CFR Part 46 and FDA 21 CFR Part 50/56. Separate ethical approval for the handling and storage of these samples was provided by Oxford Brookes University UREC. This article does not contain any studies with animals performed by any of the authors.

Document is current

Any future updates will be listed below